↓ Skip to main content

A Potent and Selective AMPK Activator That Inhibits de Novo Lipogenesis

Overview of attention for article published in ACS Medicinal Chemistry Letters, August 2010

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (63rd percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

patent
2 patents
f1000
1 research highlight platform

Readers on

mendeley
46 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
A Potent and Selective AMPK Activator That Inhibits de Novo Lipogenesis
Published in
ACS Medicinal Chemistry Letters, August 2010
DOI 10.1021/ml100143q
Pubmed ID
Authors
Abstract

AMP-activated protein kinase (AMPK) is a heterotrimeric kinase that regulates cellular energy metabolism by affecting energy-consuming pathways such as de novo lipid biosynthesis and glucose production as well as energy-producing pathways such as lipid oxidation and glucose uptake. Accordingly, compounds that activate AMPK represent potential drug candidates for the treatment of hyperlipidemia and type 2 diabetes. Screening of a proprietary library of AMP mimetics identified the phosphonic acid 2 that bears little structural resemblance to AMP but is capable of activating AMPK with high potency (EC50 = 6 nM vs AMP EC50 = 6 μM) and specificity. Phosphonate prodrugs of 2 inhibited de novo lipogenesis in cellular and animal models of hyperlipidemia.

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 46 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Japan 1 2%
Unknown 45 98%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 12 26%
Student > Ph. D. Student 8 17%
Student > Bachelor 4 9%
Student > Master 4 9%
Other 3 7%
Other 5 11%
Unknown 10 22%
Readers by discipline
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 13 28%
Agricultural and Biological Sciences 8 17%
Chemistry 8 17%
Pharmacology, Toxicology and Pharmaceutical Science 2 4%
Medicine and Dentistry 2 4%
Other 2 4%
Unknown 11 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 December 2022.
All research outputs
#10,351,676
of 33,779,198 outputs
Outputs from ACS Medicinal Chemistry Letters
#1,518
of 3,286 outputs
Outputs of similar age
#52,320
of 145,528 outputs
Outputs of similar age from ACS Medicinal Chemistry Letters
#15
of 24 outputs
Altmetric has tracked 33,779,198 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 3,286 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has gotten more attention than average, scoring higher than 51% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 145,528 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.
We're also able to compare this research output to 24 others from the same source and published within six weeks on either side of this one. This one is in the 33rd percentile – i.e., 33% of its contemporaries scored the same or lower than it.